Abstract
Regulators are now more often distinguishing between perceived good citizens and “bad actors” in stem cell and regenerative medicine clinical research, resulting in relatively more polar, carrot-and-stick oversight approaches. Here, I discuss why there may be too much carrot and not enough stick by regulators for effective enforcement. Regulators are now more often distinguishing between perceived good citizens and “bad actors” in stem cell and regenerative medicine clinical research, resulting in relatively more polar, carrot-and-stick oversight approaches. Here, I discuss why there may be too much carrot and not enough stick by regulators for effective enforcement.
Original language | English (US) |
---|---|
Journal | Cell Stem Cell |
DOIs | |
State | Accepted/In press - Jan 1 2018 |
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology